CMS Solicits Input On Coverage Of Ambulatory Blood Pressure Monitoring
Executive Summary
The agency is reopening the coverage policy on ambulatory blood pressure monitoring, non-invasive blood pressure measurement over 24-hour cycles, in response to a request from medical professional societies. Currently, Medicare only covers ABPM in limited circumstances where there is reason to believe a patient's in-office blood-pressure is not an accurate representation of their normal blood pressure.
You may also be interested in...
White Coat, Masked Hypertensives Could Win Ambulatory Blood Pressure Monitoring Coverage Under CMS Proposal
An April 9 proposed decision memo from the US Centers for Medicare and Medicaid Services would allow additional coverage for use of ambulatory blood pressure monitoring (APBM) devices by Medicare beneficiaries with known or suspected high blood pressure who meet specific criteria defined by the agency.
Medicare makes ambulatory BP (blood pressure) coverage decision
Medicare will soon begin covering ambulatory blood pressure monitoring to determine whether a patient's blood pressure is high due to fears about being in a doctor's office, or is high for any other reason that requires management.
Device Week, 21 January 2022 – J.P. Morgan Health Care Conference Highlights; Spotlight PneumoWave
On this week’s podcast, Medtech Insight's Reed Miller, Marion Webb and Barnaby Pickering provide a recap of our J.P. Morgan Health Care conference coverage including Abbott, Dexcom, Zimmer Biomet and Nuvasive and spotlight Scottish company PneumoWave.